Search
  • 網站搜尋
亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。
返回搜索結果

Removal of Low Molecular Weight Heparin as a Treatment for Heparin Overdose


標題

Heparin Affinity Tag and Applications Thereof


詳細技術說明

Heparin is an anti-coagulant that is commonly used in surgery to prevent blood from clotting during procedures such as kidney dialysis, heart bypass surgery, stent implementation, indwelling catheters and knee and hip replacements.  In about 5% of the cases of heparin usage, the patients experience uncontrolled bleeding which can be dangerous, especially for children.  Children are usually given a particular form of heparin, low molecular weight heparin.  For this form of heparin, there is currently no way to remove heparin from the blood in case of uncontrolled bleeding or heparin overdose, and the only treatment is to use an antidote, protamine sulfate.  However protamine sulfate is difficult to administer properly, and causes allergic reactions in patients that are allergic to fish. A new material has been invented that can remove heparin from the blood without its having to actually enter the patient’s body, which is a plus for patients with weak kidney function.  The new material can be placed on a cartridge such as the kind that is used in kidney dialysis, and the blood is passed over the surface of the cartridge, removing and immobilizing the heparin.  For hospitals, it would be a tool that can be used in the cases of heparin overdose or uncontrolled bleeding.  Heparin overdoses in adults are critical and in neonatal patients is often fatal. This new material can save lives.The following link provides more information on the technology, and the need for it in the marketplace. http://vpred.uark.edu/documents/techventures/tech_docs/heparin_market_report.pdf


申請日期

Aug 12, 2014


申請號碼

9,676,816


國家/地區

美國

欲了解更多信息,請點擊 這裡
Business of IP Asia Forum
桌面版